高风险子宫内膜癌微创手术与开腹手术比较:系统综述与Meta分析
该系统综述与Meta分析纳入14项研究共2332例患者,并加入Mayo Clinic 1999至2016年542例队列,比较微创与开腹手术在高风险子宫内膜癌中的生存结局。结果显示无病生存(RR 0.93,95%CI 0.82-1.05,I²=20%,P=.23)与总生存(RR 0.92,95%CI 0.77-1.11,I²=31%,P=.12)均无统计学差异,按分期亚组分析亦无差异。
要点
- 高风险子宫内膜癌微创与开腹手术的无病生存和总生存无统计学差异。
- 无病生存RR 0.93(95%CI 0.82-1.05,I²=20%,P=.23)。
- 总生存RR 0.92(95%CI 0.77-1.11,I²=31%,P=.12),按分期亚组分析无差异。
核心结论
- 在高风险子宫内膜癌患者中,微创手术与开腹手术的无病生存和总生存相似。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、EMBASE、ClinicalTrials.gov、Cochrane Central Register of Controlled Trials和Scopus截至2020年12月发表的文献。
- 系统综述纳入14项研究共2332例患者,除一项随机对照比较的亚组分析外均为回顾性研究。
- 另加入Mayo Clinic(Rochester, Minnesota)1999至2016年因高风险子宫内膜癌手术的542例队列患者。
- 高风险定义为国际妇产科联盟(FIGO)3级子宫内膜样、浆液性、透明细胞、混合组织学或子宫癌肉瘤。
- 采用随机效应模型进行Meta分析,并在PROSPERO注册(CRD42021275535)。
主要发现
- 微创手术组与开腹手术组的无病生存无统计学差异(RR 0.93,95%CI 0.82-1.05,I²=20%,P=.23)。
- 微创手术组与开腹手术组的总生存无统计学差异(RR 0.92,95%CI 0.77-1.11,I²=31%,P=.12)。
- 按分期(早期与晚期)亚组分析未发现两种手术方式之间存在差异。
关键数值与推荐
- 纳入标准为报告高风险子宫内膜癌患者总生存和无病生存原始数据的研究。
- 排除未报告至少一项主要结局的研究、与开腹手术比较分析中缺少一种微创技术(机器人或腹腔镜手术)的研究以及病例报告。
- 采用GRADE方法学与Newcastle-Ottawa量表进行质量评价,并遵循PRISMA指南。
临床怎么用
- 原文未据此给出推荐。
局限性
- 系统综述纳入的14项研究中除一项随机对照比较的亚组分析外均为回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare outcomes between minimally invasive surgery and open surgery in patients with high-risk endometrial cancer. DATA SOURCES: A cohort study of all patients who underwent surgery for high-risk endometrial cancer between 1999 and 2016 at Mayo Clinic (Rochester, Minnesota) and a literature search of MEDLINE, EMBASE, ClinicalTrials.gov, Cochrane Central Register of Controlled Trials, and Scopus of all published studies until December 2020. METHODS OF STUDY SELECTION: The systematic review identified 2,332 patients (14 studies, all retrospective except a subanalysis of a randomized comparison) and the cohort study identified 542 additional patients. Articles were included if reporting original data on overall survival and disease-free survival among patients with high-risk endometrial cancer, defined as International Federation of Gynecology and Obstetrics grade 3 endometrioid, serous, clear cell, mixed histology, or uterine carcinosarcoma. Studies that did not report at least one of the main outcomes, those in which one surgical technique (robotic or laparoscopic surgery) was missing in the comparison analysis with open surgery, and case reports were excluded. Additional data were extracted from a retrospective cohort of patients from Mayo. A random-effect model was used for meta-analysis. TABULATION, INTEGRATION, AND RESULTS: This systematic review and meta-analysis was registered in PROSPERO. Literature search and data extraction were performed independently by two reviewers, as well as quality assessment using GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology, and the Newcastle-Ottawa Scale. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were followed. Meta-analysis showed that disease-free survival and overall survival in patients with high-risk endometrial cancer who underwent minimally invasive surgery were not statistically different from those of patients who underwent open abdominal surgery (relative risk [RR] 0.93, 95% CI 0.82-1.05, I2 20%, P=.23; and RR 0.92, 95% CI 0.77-1.11, I2 31%, P=.12, respectively). Subgroup analysis by stage (early vs advanced) did not identify a difference between surgical approaches. CONCLUSION: Minimally invasive surgery and open surgery had similar disease-free survival and overall survival in patients with high-risk endometrial cancer. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42021275535.
引用
- Dinoi G, Ghoniem K, Murad MH, et al. Minimally Invasive Compared With Open Surgery in High-Risk Endometrial Cancer: A Systematic Review and Meta-analysis. Obstet Gynecol. 2022. PMID: 36701610. doi:10.1097/AOG.0000000000004995
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。